Thu, May 13, 2021
Wed, May 12, 2021
Tue, May 11, 2021

Navin Jacob Maintained (ABBV) at Strong Buy with Increased Target to $126 on, May 12th, 2021

Navin Jacob of UBS, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Increased Target from $124 to $126 on, May 12th, 2021.

Navin has made no other calls on ABBV in the last 4 months.



There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 0 agree with Navin's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Navin


  • Daniel Busby of "RBC Capital" Reiterated at Buy and Held Target at $135 on, Monday, May 3rd, 2021
  • Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $129 on, Monday, May 3rd, 2021
  • Tim Anderson of "Wolfe Research" Maintained at Buy with Increased Target to $127 on, Monday, May 3rd, 2021
  • Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $128 on, Monday, May 3rd, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $144 on, Tuesday, March 30th, 2021
  • Andrew Baum of "Citigroup" Maintained at Strong Buy with Increased Target to $125 on, Friday, March 12th, 2021
  • Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $135 on, Thursday, February 4th, 2021
  • David Risinger of "Morgan Stanley" Maintained at Buy with Decreased Target to $116 on, Thursday, January 28th, 2021